Joseph Kuechle
University of Illinois at Chicago
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph Kuechle.
American Journal of Transplantation | 2008
Antonio Gangemi; Payam Salehi; Betul Hatipoglu; Joan Martellotto; Barbara Barbaro; Joseph Kuechle; Merigeng Qi; Yong Wang; P. Pallan; Charles A. Owens; James T. Bui; Derek L. West; Bruce Kaplan; Enrico Benedetti; José Oberholzer
This prospective phase 1/2 trial investigated the safety and reproducibility of allogeneic islet transplantation (Tx) in type I diabetic (T1DM) patients and tested a strategy to achieve insulin‐independence with lower islet mass. Ten C‐peptide negative T1DM subjects with hypoglycemic unawareness received 1–3 intraportal allogeneic islet Tx and were followed for 15 months. Four subjects (Group 1) received the Edmonton immunosuppression regimen (daclizumab, sirolimus, tacrolimus). Six subjects (Group 2) received the University of Illinois protocol (etanercept, exenatide and the Edmonton regimen). All subjects became insulin‐ independent. Group 1 received a mean total number of islets (EIN) of 1460 080 ± 418 330 in 2 (n = 2) or 3 (n = 2) Tx, whereas Group 2 became insulin‐ independent after 1 Tx (537 495 ± 190 968 EIN, p = 0.028). All Group 1 subjects remained insulin free through the follow‐up. Two Group 2 subjects resumed insulin: one after immunosuppression reduction during an infectious complication, the other with exenatide intolerance. HbA1c reached normal range in both groups (6.5 ± 0.6 at baseline to 5.6 ± 0.5 after 2–3 Tx in Group 1 vs. 7.8 ± 1.1 to 5.8 ± 0.3 after 1 Tx in Group 2). HYPO scores markedly decreased in both groups. Combined treatment of etanercept and exenatide improves islet graft function and facilitates achievement of insulin‐independence with less islets.
Artificial Cells, Blood Substitutes, and Biotechnology | 2008
Meirigeng Qi; Berit Løkensgard Strand; Yrr A. Mørch; Igor Lacík; Yong Wang; Payam Salehi; Barbara Barbaro; Antonio Gangemi; Joseph Kuechle; Travis Romagnoli; Michael A. Hansen; Lisette Rodriguez; Enrico Benedetti; David Hunkeler; Gudmund Skjåk-Bræk; José Oberholzer
Microencapsulation may allow for immunosuppression-free islet transplantation. Herein we investigated whether human islets can be shipped safely to a remote encapsulation core facility and maintain in vitro and in vivo functionality. In non-encapsulated islets before and encapsulated islets after shipment, viability was 88.3±2.5 and 87.5±2.7% (n=6, p=0.30). Stimulation index after static glucose incubation was 5.4±0.5 and 6.3±0.4 (n=6, p=0.18), respectively. After intraperitoneal transplantation, long-term normoglycemia was consistently achieved with 3,000, 5,000, and 10,000 IEQ encapsulated human islets. When transplanting 1,000 IEQ, mice returned to hyperglycemia after 30-55 (n=4/7) and 160 days (n=3/7). Transplanted mice showed human oral glucose tolerance with lower glucose levels than non-diabetic control mice. Capsules retrieved after transplantation were intact, with only minimal overgrowth. This study shows that human islets maintained the viability and in vitro function after encapsulation and the inhomogeneous alginate-Ca2+/Ba2+ microbeads allow for long-term in vivo human islet graft function, despite long-distance shipment.
American Journal of Transplantation | 2005
Jose G. Avila; Barbara Barbaro; Antonio Gangemi; Travis Romagnoli; Joseph Kuechle; Michael A. Hansen; James Shapiro; Giuliano Testa; Howard Sankary; Enrico Benedetti; Jonathan R. T. Lakey; Jose Oberholzer
Oxidative stress during islet isolation induces a cascade of events injuring islets and hampering islet engraftment. This study evaluated islet isolation and transplantation outcomes after intra‐ductal glutamine administration. Human pancreata deemed unsuitable for pancreas or islet transplantation were treated with either a 5 mM solution of l‐glutamine (n = 6) or collagenase enzyme alone (n = 6) through the main pancreatic duct. Islet yield, viability, in vitro function; markers of oxidative stress [malondialdehyde (MDA) and Glutathione (GSH)] and apoptosis were assessed. Islet yields were significantly increased in the glutamine group compared to controls (318, 559 ± 25, 800 vs. 165, 582 ± 39, 944 mean ± SEM, p < 0.01). The amount of apoptotic cells per islet was smaller in the glutamine group than the control. The percentage of nude mice rendered normoglycemic with glutamine‐treated islets was higher than the controls (83% n = 10/12 vs. 26% n = 6/23; p < 0.01), and the time to reach normoglycemia was decreased in the glutamine group (1.83 ± 0.4 vs. 7.3 ± 3 days; p < 0.01). Glutamine administration increased GSH levels (7.6 ± 1.7 nmol/mg protein vs. 4.03 ± 0.5 in control, p < 0.05) and reduced lipid‐peroxidation (MDA 2.45 ± 0.7 nmol/mg of protein vs. 6.54 ± 1.7 in control; p < 0.05). We conclude that intra‐ductal administration of glutamine reduces oxidative injury and apoptosis and improves islet yield and islet graft function after transplantation.
American Journal of Transplantation | 2006
Jose G. Avila; Yong Wang; Barbara Barbaro; Antonio Gangemi; Merigeng Qi; Joseph Kuechle; N. Doubleday; M. Doubleday; Thomas A. Churchill; Payam Salehi; James Shapiro; Louis H. Philipson; Enrico Benedetti; Jonathan R. T. Lakey; José Oberholzer
During isolation, islets are exposed to warm ischemia. In this study, intraductal administration of oxygenated polymerized, stroma‐free hemoglobin‐pyridoxalated (Poly SFH‐P) was performed to improve O2 delivery. Rat pancreata subjected to 30‐min warm ischemia were perfused intraductally with collagenase in oxygenated Poly SFH‐P/RPMI or RPMI (control). PO2 was increased by Poly SFH‐P (381.7 ± 35.3 mmHg vs. 202.3 ± 28.2, p = 0.01) and pH maintained within physiological range (7.4–7.2 vs. 7.1–6.6, p = 0.009). Islet viability (77%± 4.6 vs. 63%± 4.7, p = 0.04) was improved and apoptosis lower with Poly SFH‐P (caspase‐3: 34,714 ± 2167 vs. 45,985 ± 1382, respectively, p = 0.01). Poly SFH‐P improved islet responsiveness to glucose as determined by increased intracellular Ca2+ levels and improved insulin secretion (SI 5.4 ± 0.1 vs. 3.1 ± 0.2, p = 0.03). Mitochondrial integrity was improved in Poly SFH‐P‐treated islets, which showed higher percentage change in membrane potential after glucose stimulation (14.7%± 1.8 vs. 9.8 ± 1.4, respectively, p < 0.05). O2 delivery by Poly SFH‐P did not increase oxidative stress (GSH 7.1 ± 2.9 nm/mg protein for Poly SFH‐P vs. 6.8 ± 2.4 control, p = 0.9) or oxidative injury (MDA 1.8 ± 0.9 nmol/mg protein vs. 6.2 ± 2.4, p = 0.19). Time to reach normoglycemia in transplanted diabetic nude mice was shorter (1.8 ± 0.4 vs. 7 ± 2.5 days, p = 0.02), and glucose tolerance improved in the Poly SFH‐P group (AUC 8106 ± 590 vs. 10,863 ± 946, p = 0.03). Oxygenated Poly SFH‐P improves islet isolation and transplantation outcomes by preserving mitochondrial integrity.
Artificial Cells, Blood Substitutes, and Biotechnology | 2008
Barbara Barbaro; Joseph Kuechle; Payam Salehi; Lisette Rodriguez; Merigeng Qi; Antonio Gangemi; Enrico Benedetti; José Oberholzer
Providing sufficient islet mass is important for successful islet transplantation. Apoptosis plays a major role in post-isolation islet cell death, and prevention of apoptosis could improve transplant outcomes. The purpose of this study was to determine whether increased concentration of human albumin (HA) in pre-transplantation culture of human islets would reduce apoptosis. Human islets were cultured in CMRL with 1.5 or 5% of HA for 24 h and apoptosis was evaluated indirectly by measuring caspase 3 activity and tetramethylrhodamine-ethyl-ester (TMRE) in dissociated islets. Islet function and viability were evaluated. Islets cultured in higher albumin concentration presented with lower caspase 3 activity (43.9 ± 3.9 vs. 67.4 ± 11.1, p = 0.011), and had increased insulin secretory capacity (Stimulation index 3.76 ± 0.91 vs 1.23 ± 0.21, p = 0.023). We conclude that an increase in albumin concentration can prevent apoptosis in isolated human islets. These findings may have implications for islet transplant outcomes.
International Journal of Surgery Case Reports | 2015
Joseph Kuechle; Brian E. McGrath; Thaer Khoury
Highlights • Patients with limited, skeletal only recurrent breast Ca have better survival than widespread metastatic disease.• The osteotropic phenotype may directly affect mortality.
International Journal of Surgical Pathology | 2011
Joseph Kuechle; Seema Pasha; Kamel Sadat; Jay Tran; Betul Hatipoglu; James T. Bui; Gregorio Chejfec; José Oberholzer
A case of a pulmonary sequestration, which almost exclusively consisted of a congenital cystic adenomatoid malformation type II located subdiaphragmatically in the left retroperitoneal area, is reported. This case, in a 24-year-old male patient, is unique in that it appeared as an adrenal incidentaloma and extended through a Bochdalek hernia into the pleural space. It was discovered upon routine ultrasound screening for hepatocellular carcinoma in a patient with a carrier state for hepatitis B. Diagnosis was established only upon histological analysis of the surgically removed tumor after staining with hematoxylin and eosin as well as surfactant A and B. The location of the tumor may indicate that it was formed by an entrapment of a lung bud by the developing diaphragm. This appearance may give us insight into the formation of such tumors. It also highlights the difficulty of diagnosing subdiaphragmatic retroperitoneal tumors without histological examination.
Arthroscopy techniques | 2014
Brian E. McGrath; Joseph Kuechle
Hip arthroscopy has been shown to be an effective technique in managing an increasingly widening set of indications for hip pathology. In any arthroscopic procedure, obtaining good visualization is one of the most critical components to performing a successful operation. Whereas other authors have described various techniques for improving visualization, we describe an additional simple but effective technique in this report. We describe the use of a retracting suture bridge between portal sites that allows for improved visualization of the peripheral compartment in hip arthroscopy, as well as other arthroscopic procedures.
Genes & Development | 2004
Vladimir V. Kalinichenko; Michael L. Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M. Yoder; Margaret B. Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H. Costa
Transplantation | 2007
Barbara Barbaro; Payam Salehi; Yong Wang; Meirigeng Qi; Antonio Gangemi; Joseph Kuechle; Michael A. Hansen; Travis Romagnoli; Jose G. Avila; Enrico Benedetti; Raymond Mage; José Oberholzer